Tenax Therapeutics (TENX) Other Non-Current Liabilities (2012 - 2019)
Tenax Therapeutics (TENX) reported Other Non-Current Liabilities of $8775.0 for Q4 2019, down 31.08% on a YoY basis from $12732.0 in Q4 2018, and down 31.08% sequentially from $12732.0 in Q4 2018.
Tenax Therapeutics (TENX) Other Non-Current Liabilities (2012 - 2019) Analysis & Trends
Tenax Therapeutics (TENX) has 7 years of Other Non-Current Liabilities data on file, last reported at $8775.0 in Q4 2019.
- For the quarter ending Q4 2019, Other Non-Current Liabilities fell 31.08% year-over-year to $8775.0; the trailing twelve-month figure through Dec 2019 stood at $8775.0 (down 31.08% YoY), and the FY2019 full-year result was $8775.0, down 31.08% from the prior year.
- Other Non-Current Liabilities fell to $8775.0 in Q4 2019, from $12732.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $572445.0 in Q2 2015 to a low of $8775.0 in Q4 2019.
- A 5-year average of $163351.4 and a median of $45699.0 in 2017 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities slumped 88.37% in 2017 and tumbled 31.08% in 2019, its largest moves.
- Tracing TENX's Other Non-Current Liabilities over 5 years: stood at $524340.0 in 2015, then slumped by 56.88% to $226092.0 in 2016, then tumbled by 85.11% to $33673.0 in 2017, then tumbled by 62.19% to $12732.0 in 2018, then slumped by 31.08% to $8775.0 in 2019.
- Business Quant data shows TENX's Other Non-Current Liabilities at $8775.0 in Q4 2019, $12732.0 in Q4 2018, and $19376.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 8,775.00 |
| Dec 31, 2018 | 12,732.00 |
| Sep 30, 2018 | 19,376.00 |
| Jun 30, 2018 | 24,551.00 |
| Mar 31, 2018 | 20,700.00 |
| Dec 31, 2017 | 33,673.00 |
| Sep 30, 2017 | 36,078.00 |
| Jun 30, 2017 | 72,157.00 |
| Mar 31, 2017 | 55,320.00 |
| Dec 31, 2016 | 226,092.00 |
| Sep 30, 2016 | 310,275.00 |
| Jun 30, 2016 | 370,405.00 |
| Dec 31, 2015 | 524,340.00 |
| Apr 30, 2015 | 572,445.00 |
| Apr 30, 2013 | 54,660.00 |
| Jan 31, 2013 | 65,592.00 |
| Oct 31, 2012 | 76,524.00 |